John R. Moore - 20 Sep 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
General Counsel
Signature
/s/ John R. Moore
Issuer symbol
EWTX
Transactions as of
20 Sep 2024
Net transactions value
-$1,946,220
Form type
4
Filing time
24 Sep 2024, 20:25:15 UTC
Previous filing
14 Aug 2024
Next filing
07 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $35,500 +50,000 +1538% $0.7100 53,252 20 Sep 2024 Direct
transaction EWTX Common Stock Sale $1,418,510 -50,000 -94% $28.37 3,252 20 Sep 2024 Direct
transaction EWTX Common Stock Options Exercise $14,855 +20,922 +643% $0.7100 24,174 23 Sep 2024 Direct
transaction EWTX Common Stock Sale $578,064 -20,922 -87% $27.63 3,252 23 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -50,000 -44% $0.000000 62,558 20 Sep 2024 Common Stock 50,000 $0.7100 Direct F1
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -20,922 -33% $0.000000 41,636 23 Sep 2024 Common Stock 20,922 $0.7100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.